News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
211,103 Results
Type
Article (7153)
Company Profile (38)
Press Release (203912)
Multimedia
Podcasts (23)
Webinars (5)
Section
Business (55531)
Career Advice (173)
Deals (10640)
Drug Delivery (45)
Drug Development (12392)
Employer Resources (35)
FDA (5793)
Job Trends (5352)
News (86935)
Policy (8649)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
Academia (704)
Accelerated approval (1)
Adcomms (1)
Allergies (31)
Alliances (15261)
ALS (13)
Alzheimer's disease (332)
Antibody-drug conjugate (ADC) (23)
Approvals (5855)
Artificial intelligence (149)
Autoimmune disease (5)
Automation (4)
Bankruptcy (67)
Best Places to Work (4871)
BIOSECURE Act (4)
Biosimilars (54)
Biotechnology (18)
Bladder cancer (22)
Brain cancer (3)
Breast cancer (93)
Cancer (558)
Cardiovascular disease (66)
Career advice (165)
Career pathing (1)
CAR-T (20)
Cell therapy (82)
Cervical cancer (7)
Clinical research (10588)
Collaboration (284)
Compensation (23)
Complete response letters (2)
COVID-19 (732)
CRISPR (11)
C-suite (100)
Cystic fibrosis (18)
Data (635)
Decentralized trials (1)
Denatured (9)
Depression (13)
Diabetes (88)
Diagnostics (3219)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (36)
Drug pricing (46)
Drug shortages (6)
Duchenne muscular dystrophy (33)
Earnings (17939)
Editorial (14)
Employer branding (1)
Employer resources (31)
Events (48164)
Executive appointments (302)
FDA (6268)
Featured Employer (10)
Frontotemporal dementia (3)
Funding (264)
Gene editing (24)
Generative AI (17)
Gene therapy (69)
GLP-1 (176)
Government (1355)
Grass and pollen (2)
Guidances (26)
Healthcare (8618)
Huntington's disease (2)
IgA nephropathy (11)
Immunology and inflammation (19)
Indications (12)
Infectious disease (784)
Inflammatory bowel disease (38)
Inflation Reduction Act (5)
Influenza (14)
Intellectual property (20)
Interviews (15)
IPO (4301)
IRA (16)
Job creations (710)
Job search strategy (154)
Kidney cancer (1)
Labor market (3)
Layoffs (76)
Legal (1651)
Liver cancer (16)
Lung cancer (77)
Lymphoma (37)
Machine learning (2)
Management (14)
Manufacturing (76)
MASH (19)
Medical device (6135)
Medtech (6135)
Mergers & acquisitions (6597)
Metabolic disorders (229)
Multiple sclerosis (35)
NASH (5)
Neurodegenerative disease (17)
Neuropsychiatric disorders (7)
Neuroscience (458)
NextGen: Class of 2025 (2903)
Non-profit (1544)
Northern California (772)
Now hiring (2)
Obesity (126)
Opinion (66)
Ovarian cancer (14)
Pain (20)
Pancreatic cancer (12)
Parkinson's disease (22)
Partnered (7)
Patents (38)
Patient recruitment (34)
Peanut (19)
People (18590)
Pharmaceutical (12)
Pharmacy benefit managers (8)
Phase I (2232)
Phase II (3719)
Phase III (5058)
Pipeline (377)
Policy (47)
Postmarket research (735)
Preclinical (718)
Press Release (10)
Prostate cancer (36)
Psychedelics (5)
Radiopharmaceuticals (75)
Rare diseases (107)
Real estate (1405)
Recruiting (11)
Regulatory (6329)
Reports (16)
Research institute (627)
Resumes & cover letters (13)
Rett syndrome (3)
RNA editing (1)
RSV (17)
Schizophrenia (19)
Series A (41)
Series B (38)
Service/supplier (3)
Sickle cell disease (25)
Southern California (648)
Special edition (6)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1229)
Stomach cancer (2)
Supply chain (23)
Tariffs (10)
The Weekly (14)
United States (7634)
Vaccines (157)
Venture capitalists (17)
Weight loss (64)
Women's health (20)
Worklife (2)
Date
Today (63)
Last 7 days (155)
Last 30 days (816)
Last 365 days (11567)
2025 (3776)
2024 (11926)
2023 (13068)
2022 (20209)
2021 (21553)
2020 (20909)
2019 (17773)
2018 (13130)
2017 (8988)
2016 (9590)
2015 (11013)
2014 (8137)
2013 (6719)
2012 (7005)
2011 (6970)
2010 (5591)
Location
Africa (230)
Alabama (14)
Alaska (1)
Arizona (69)
Arkansas (6)
Asia (10980)
Australia (1468)
California (1733)
Canada (611)
China (160)
Colorado (119)
Connecticut (81)
Delaware (47)
Europe (26534)
Florida (309)
Georgia (90)
Hawaii (1)
Idaho (18)
Illinois (221)
India (17)
Indiana (137)
Iowa (1)
Japan (78)
Kansas (23)
Kentucky (13)
Louisiana (8)
Maine (26)
Maryland (235)
Massachusetts (1412)
Michigan (89)
Minnesota (131)
Mississippi (2)
Missouri (54)
Montana (5)
Nebraska (13)
Nevada (16)
New Hampshire (24)
New Jersey (689)
New Mexico (7)
New York (604)
North Carolina (404)
North Dakota (1)
Northern California (772)
Ohio (65)
Oklahoma (6)
Oregon (11)
Pennsylvania (508)
Puerto Rico (3)
Rhode Island (8)
South America (310)
South Carolina (9)
Southern California (648)
Tennessee (70)
Texas (252)
Utah (99)
Virginia (42)
Washington D.C. (25)
Washington State (148)
West Virginia (3)
Wisconsin (23)
211,103 Results for "sensus healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting
March 6, 2025
·
6 min read
Press Releases
Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
March 5, 2025
·
5 min read
BioMidwest
Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia
Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the sale of the first SRT-100 Vision™ system in Asia, to Far Eastern Memorial Hospital in Taiwan.
May 6, 2024
·
6 min read
Press Releases
Sensus Healthcare Sells SRT System to Providence Swedish Hospital
September 26, 2024
·
5 min read
BioMidwest
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare, Inc. announces management will participate in one-on-one or small group meetings with institutional investors at the 36th Annual Roth conference to be held March 17th – 19th in Dana Point, Calif.
March 14, 2024
·
4 min read
Business
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
Sensus Healthcare, Inc. announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders.
February 1, 2024
·
2 min read
Business
Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold
Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2024.
May 9, 2024
·
14 min read
Business
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
Sensus Healthcare, Inc. announces that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024.
April 18, 2024
·
1 min read
Press Releases
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
November 15, 2024
·
16 min read
Business
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
Sensus Healthcare, Inc. reminds investors that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024.
April 25, 2024
·
1 min read
1 of 21,111
Next
